Betrixaban is an oral anticoagulant that acts as a direct factor Xa inhibitor, used as a pharmaceutical raw material for manufacturing anticoagulant medications. It is noted for its relatively low renal excretion and lack of metabolism by CYP3A4 compared to other direct oral anticoagulants.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 330942-05-7
1-AMINOADAMATANE, 3-METHYL
pharmaceutical raw material
Zinc ascorbate
pharmaceutical raw material
Etomidate
pharmaceutical raw material
(Z)-thiothixene
pharmaceutical raw material
N-(5-chloro-2-pyridinyl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide
XHOLNRLADUSQLD-UHFFFAOYSA-N
CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl